University of California, Merced Professor of Systems Biology and Cancer Metabolism, Fabian Filipp, uses a multipipettor to transfer human tumor cells while explaining the process of High-throughput screening, a test to indicate which drugs and which regulators the cells respond to at the Science and Engineering Building 2 on the campus of UC Merced in Merced, Calif., on Thursday, March 2, 2017. Filipp is working to understand epigenetic mechanisms to develop precision targeting of cancer cells for personalized medicine.
University of California, Merced Professor of Systems Biology and Cancer Metabolism, Fabian Filipp, uses a multipipettor to transfer human tumor cells while explaining the process of High-throughput screening, a test to indicate which drugs and which regulators the cells respond to at the Science and Engineering Building 2 on the campus of UC Merced in Merced, Calif., on Thursday, March 2, 2017. Filipp is working to understand epigenetic mechanisms to develop precision targeting of cancer cells for personalized medicine. Andrew Kuhn akuhn@mercedsunstar.com
University of California, Merced Professor of Systems Biology and Cancer Metabolism, Fabian Filipp, uses a multipipettor to transfer human tumor cells while explaining the process of High-throughput screening, a test to indicate which drugs and which regulators the cells respond to at the Science and Engineering Building 2 on the campus of UC Merced in Merced, Calif., on Thursday, March 2, 2017. Filipp is working to understand epigenetic mechanisms to develop precision targeting of cancer cells for personalized medicine. Andrew Kuhn akuhn@mercedsunstar.com

Cancer learns to resist treatment, UC Merced team finds. It's not all bad news

April 09, 2018 04:25 PM